Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor

نویسندگان

  • Masataka Yoshida
  • Takahiro Takazono
  • Masato Tashiro
  • Tomomi Saijo
  • Yoshitomo Morinaga
  • Kazuko Yamamoto
  • Shigeki Nakamura
  • Yoshifumi Imamura
  • Taiga Miyazaki
  • Toyomitsu Sawai
  • Tomoya Nishino
  • Koichi Izumikawa
  • Katsunori Yanagihara
  • Hiroshi Mukae
  • Shigeru Kohno
چکیده

Streptococcal toxic shock syndrome caused by group B streptococcus (GBS) is a rare, but lethal disease. We experienced a 45-year-old woman with pustular psoriasis who developed toxic shock-like syndrome during infliximab treatment. Surprisingly, similar episodes recurred three times in one year with restarting of infliximab treatments. In the third episode, GBS were detected in blood, urine, and vaginal secretion cultures. These episodes of shock syndrome were possibly due to GBS. To the best of our knowledge, this is the first case report of recurrent streptococcal toxic shock syndrome possibly caused by GBS which was induced by anti-TNF-α inhibitor therapy. The restarting of biological agents in patients with a history of toxic shock syndrome should therefore be avoided as much as possible.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Streptococcus agalactiae Toxic Shock-Like Syndrome

We present 2 patients with Streptococcus agalactiae toxic shock-like syndrome and review another 11 well-reported cases from the literature. Streptococcal toxic shock-like syndrome is a devastating illness with a high mortality rate, therefore we stress the importance of early supportive management, antimicrobial therapy, and surgical intervention. Toxic shock-like syndrome is likely to be unde...

متن کامل

Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae.

We describe 2 cases of fatal necrotizing fasciitis and toxic shock syndrome caused by Streptococcus agalactiae-a rare entity that has been reported in only 9 patients-in 2 nonpregnant adults.

متن کامل

Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom

We describe successful management of 3 patients with streptococcal toxic shock syndrome (STSS) attributable to group G Streptococcus infection. This small series supports recognition of group G Streptococcus in the etiology of STSS. We propose intravenous immunoglobulin be used in treatment as it is for STSS caused by group A Streptococcus.

متن کامل

Structural studies of superantigens: Crystal structure of Streptococcus dysgalactiae-derived mitogen (SDM)

Superantigens are a family of bacterial and viral toxins that are able to induce a massive T-cell activation [1,2]. Compared to conventional antigens where only 0.0001-0.01% of T-cells are activated, superantigens are able to activate 10-30% of T-cells. Superantigen-induced T-cell activation results in an extensive production of inflammatory cytokines, such as tumor necrosis factor and interleu...

متن کامل

Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited

Gene mutations in the virulence regulator CovR/S of group A Streptococcus play a substantial role in the pathogenesis of streptococcal toxic shock syndrome. We screened 25 group B Streptococcus (GBS) isolates obtained from patients with streptococcal toxic shock syndrome and found only 1 GBS clone harboring this kind of mutation.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 55  شماره 

صفحات  -

تاریخ انتشار 2016